KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $15,405,000 | -9.5% | 822,500 | +0.7% | 0.32% | -3.9% |
Q2 2021 | $17,030,000 | -15.2% | 816,800 | +15.0% | 0.34% | -23.1% |
Q1 2021 | $20,073,000 | +21.0% | 710,035 | +39.7% | 0.44% | +24.4% |
Q4 2020 | $16,595,000 | +134.1% | 508,116 | +25.5% | 0.35% | +37.0% |
Q3 2018 | $7,088,000 | -2.6% | 405,000 | +1.2% | 0.26% | -8.2% |
Q2 2018 | $7,280,000 | +1364.8% | 400,000 | +1409.4% | 0.28% | +1233.3% |
Q1 2018 | $497,000 | – | 26,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |